Cargando…
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
One of the primary genetic risk factors for Alzheimer’s disease (AD) is the presence of the Ɛ4 allele of apolipoprotein E (APOE). APOE is a polymorphic lipoprotein that is a major cholesterol carrier in the brain. It is also involved in various cellular functions such as neuronal signaling, neuroinf...
Autores principales: | Williams, Tosha, Borchelt, David R., Chakrabarty, Paramita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995170/ https://www.ncbi.nlm.nih.gov/pubmed/32005122 http://dx.doi.org/10.1186/s13024-020-0358-9 |
Ejemplares similares
-
Astrocytic apoE4 and tau: Deadly combination for neurons
por: Chakrabarty, Paramita, et al.
Publicado: (2021) -
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
por: Vecchio, Filomena Lo, et al.
Publicado: (2022) -
Apolipoprotein E and Alzheimer's disease
por: Troutwine, Benjamin R., et al.
Publicado: (2022) -
Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
por: Suidan, Georgette L., et al.
Publicado: (2019) -
Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities
por: Cedazo-Mínguez, Angel
Publicado: (2007)